Tag: ANDA approval
3 July 2026
Deficiency Letters in Generic Applications: Common FDA Findings Explained
Explore common FDA deficiency letters in generic drug applications. Learn about top findings in ANDA reviews, including dissolution issues, impurities, and bioequivalence challenges, and how to avoid them.
5 January 2026
Tentative Approval for Generics: Common Reasons for Delays
Tentative approval from the FDA means a generic drug is scientifically ready-but legal, manufacturing, or market barriers often delay its launch for years. Here’s why affordable alternatives still take so long to reach patients.